ImmunoGen, Inc.
IMGN · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $606 | $572 | $201 | $275 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $131 | $80 | $31 | $18 |
| Inventory | $5 | $3 | $1 | -$29 |
| Other Curr. Assets | $25 | $14 | $11 | $11 |
| Total Curr. Assets | $736 | $572 | $201 | $275 |
| Property Plant & Equip (Net) | $17 | $13 | $14 | $15 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $69 | $130 | $73 | $59 |
| Total NC Assets | $86 | $142 | $87 | $74 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $822 | $714 | $288 | $349 |
| Liabilities | – | – | – | – |
| Payables | $25 | $18 | $32 | $45 |
| Short-Term Debt | -$25 | $4 | $4 | $4 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $37 | $14 | $13 | $14 |
| Other Curr. Liab. | $97 | $57 | $52 | $59 |
| Total Curr. Liab. | $135 | $94 | $102 | $122 |
| LT Debt | $72 | $72 | $10 | $11 |
| Deferred Rev, NC | $27 | $30 | $34 | $36 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | -$11 |
| Other NC Liab. | $27 | $28 | $21 | $35 |
| Total NC Liab. | $126 | $130 | $65 | $71 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $261 | $223 | $166 | $193 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2 | $2 | $2 | $2 |
| Retained Earnings | -$1,709 | -$1,739 | -$1,735 | -$1,694 |
| AOCI | $2,270 | $2,230 | $1,857 | $1,850 |
| Other Equity | -$2 | -$2 | -$2 | -$2 |
| Total Equity | $562 | $491 | $122 | $156 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $822 | $714 | $288 | $349 |
| Net Debt | -$558 | -$496 | -$187 | -$260 |